In collaboration with Dr. Cecilia Hillard, Dr. Lisdahl has an ongoing study aimed at understanding the role of the endocannabinoid system in adolescent neurodevelopment, psychopathology, and substance use risk.
Dr. Lisdahl is the PI on a NIDA-funded R21 project examining the relationship between circulating endocannabinoid levels and neurocognitive, psychopathology, and substance use outcomes in a subsample of youth enrolled in the ABCD study.